4/18
09:22 am
zura
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
High
Report
Zura Bio Announces Oversubscribed $112.5 Million Private Placement
4/8
06:00 am
zura
Zura Bio Announces Robert Lisicki as CEO and Director
Low
Report
Zura Bio Announces Robert Lisicki as CEO and Director
4/1
10:15 am
zura
Zura Bio Limited (NASDAQ: ZURA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $16.00 price target on the stock, down previously from $17.00.
High
Report
Zura Bio Limited (NASDAQ: ZURA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $16.00 price target on the stock, down previously from $17.00.
3/28
06:09 am
zura
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer [Yahoo! Finance]
Medium
Report
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer [Yahoo! Finance]
3/28
06:00 am
zura
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
Medium
Report
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
3/4
06:00 am
zura
Zura Bio Announces Participation at March Conferences
High
Report
Zura Bio Announces Participation at March Conferences
2/2
06:00 am
zura
Zura Bio Announces Participation at February Investor Conferences
Low
Report
Zura Bio Announces Participation at February Investor Conferences